⌘K

Login Start Free

Home/Filings/4/0001127602-22-007717

4//SEC Filing

ASELAGE STEVE 4

Accession 0001127602-22-007717

CIK 0000882796other

View on SEC.gov Company Profile

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 4:34 PM ET

Size

4.4 KB

Accession

0001127602-22-007717

Insider Transaction Report

Form 4

Period: 2022-02-28

BIOCRYST PHARMACEUTICALS INCBCRX

Director

Transactions

Award
Common Stock
2022-02-28$16.61/sh+301$5,000→ 33,159 total

Footnotes (1)

[F1]Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $10,000.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeother

Related Parties

1

filerCIK 0001221599

Filing Metadata

Form type: 4
Filed: Mar 1, 7:00 PM ET
Accepted: Mar 2, 4:34 PM ET
Size: 4.4 KB

View on SEC.gov